Hypera Pharma: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
Tags: Mobile edit Mobile web edit
No edit summary
Tags: Mobile edit Mobile web edit Advanced mobile edit
 
(25 intermediate revisions by 15 users not shown)
Line 1: Line 1:
{{Short description|Brazilian pharmaceutical}}
{{Infobox company
{{Infobox company
| name = Hypera Pharma S.A.
| name = Hypera S.A.
| type = [[Public company|Public]]<br>([[S.A. (corporation)|Sociedade Anônima]])
| logo =
| former_names =
| type = [[S.A. (corporation)|Sociedade Anônima]]
| traded_as = {{ubl|{{BM&F Bovespa|cvm=21431|HYPE3}}}} <br />[[Ibovespa|Ibovespa Component]]
| traded_as = {{ubl|{{B3 (stock exchange)|cvm=21431|HYPE3}}}}[[Ibovespa|Ibovespa Component]]
| foundation = {{Start date and age|2001}}
| foundation = {{Start date and age|2001}} (as Prátika Industrial)
| location = [[São Paulo]], [[Brazil]]
| location = [[São Paulo]], Brazil
| key_people = Claudio Bergamo,<small>([[CEO]])</small>
| key_people = Breno Oliveira, <small>([[CEO]])</small>
| num_employees = 6.500
| num_employees = 7,515 (Dec 2019)
| industry = [[Pharmaceuticals]]
| industry = [[Pharmaceutical industry|Pharmaceutical]]
| market cap =
| products = [[Drugs]]<br />[[Healthcare]]<br /> [[Cosmetics]]
| products = [[Drugs]]<br />[[Healthcare]]<br /> [[Cosmetics]]
| revenue = {{profit}} US$ 1.8&nbsp;billion <small>(2016)</small><ref name="terra">[http://not.economia.terra.com.br/noticias/noticia.aspx?idNoticia=201103141017_TRR_1300097629nN11127018 Terra.com (Portuguese language)] {{webarchive|url=https://web.archive.org/web/20110706154528/http://not.economia.terra.com.br/noticias/noticia.aspx?idNoticia=201103141017_TRR_1300097629nN11127018 |date=2011-07-06 }}</ref>
| revenue = {{profit}} US$ 1.1&nbsp;billion <small>(2017)</small><ref name="terra">[http://not.economia.terra.com.br/noticias/noticia.aspx?idNoticia=201103141017_TRR_1300097629nN11127018 Terra.com (Portuguese language)] {{webarchive|url=https://web.archive.org/web/20110706154528/http://not.economia.terra.com.br/noticias/noticia.aspx?idNoticia=201103141017_TRR_1300097629nN11127018 |date=2011-07-06 }}</ref>
| operating_income=
| operating_income=
| net_income = {{increase}} US$ 108.6&nbsp;million <small>(2016)</small><ref name="terra" />
| net_income = {{decrease}} US$ 297.8&nbsp;million <small>(2017)</small><ref name="terra" />
| subsid = [[Mantecorp]]
| subsid = Mantecorp
| equity =
| equity =
| homepage = [http://www.hyperapharma.com.br www.hyperapharma.com.br]
| homepage = [http://www.hyperapharma.com.br www.hyperapharma.com.br]
}}
}}
'''Hypera Pharma''' is a Brazilian [[multinational corporation|multinational]] [[Medication|pharmaceutical]]

company and is the Brazilian largest pharmaceutical company by market capitalization.{{Citation needed|date=March 2023}} Headquartered in [[São Paulo]], its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products.
'''Hypera Pharma''' previously known as Hypermarcas is the Brazilian largest [[pharmaceutical]] company in terms of revenue and market capitalizar íon. Its headquarters are located in [[São Paulo]]. The company was formerly known as Hypermarcas, before a corporate name change that was announced in December 2017.<ref>{{Cite news|url=http://www.valor.com.br/empresas/5217049/hypermarcas-quer-crescer-ate-3-acima-do-mercado-em-quatro-anos|title=Hypermarcas quer crescer até 3% acima do mercado em quatro anos|work=Valor Econômico|date=2017-12-04|language=pt-br}}</ref> The official corporate name change is pending approval by the company's Shareholders' Meeting.

Hypera Pharma's main market segments are Consumer Health, Branded Prescription and Branded Generics.


==References==
==References==
Line 27: Line 25:


==External links==
==External links==
[http://www.hyperapharma.com.br Hypera Pharma]
* [http://www.hyperapharma.com.br Hypera Pharma]


{{Ibovespa companies}}
{{Ibovespa companies}}
Line 34: Line 32:
[[Category:Manufacturing companies based in São Paulo]]
[[Category:Manufacturing companies based in São Paulo]]
[[Category:Pharmaceutical companies of Brazil]]
[[Category:Pharmaceutical companies of Brazil]]
[[Category:Companies listed on the São Paulo Stock Exchange]]
[[Category:Companies listed on B3 (stock exchange)]]
[[Category:Brazilian brands]]
[[Category:Brazilian brands]]

Latest revision as of 01:34, 18 September 2023

Hypera S.A.
Company typePublic
(Sociedade Anônima)
Ibovespa Component
IndustryPharmaceutical
Founded2001; 23 years ago (2001) (as Prátika Industrial)
HeadquartersSão Paulo, Brazil
Key people
Breno Oliveira, (CEO)
ProductsDrugs
Healthcare
Cosmetics
RevenueIncrease US$ 1.1 billion (2017)[1]
Decrease US$ 297.8 million (2017)[1]
Number of employees
7,515 (Dec 2019)
SubsidiariesMantecorp
Websitewww.hyperapharma.com.br

Hypera Pharma is a Brazilian multinational pharmaceutical company and is the Brazilian largest pharmaceutical company by market capitalization.[citation needed] Headquartered in São Paulo, its business include pharmaceuticals, consumer healthcare and cosmetics products, and biotechnology products.

References[edit]

External links[edit]